| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
* Division of Oral Health and Systemic Disease/Department of Periodontics, and
Department of Microbiology and Immunology, University of Louisville Health Sciences Center, Louisville, KY 40292
The ability of certain pathogens to exploit innate immune function allows them to undermine immune clearance and thereby increase their persistence and capacity to cause disease. Porphyromonas gingivalis is a major pathogen in periodontal disease and is associated with increased risk of systemic conditions. We have previously shown that the fimbriae of P. gingivalis interact with complement receptor 3 (CR3; CD11b/CD18) in monocytes/macrophages, resulting in inhibition of IL-12p70 production in vitro. The in vivo biological implications of this observation were investigated in this study using a CR3 antagonist (XVA143). XVA143 was shown to block CR3 binding of P. gingivalis fimbriae and reverse IL-12p70 inhibition; specifically, CR3 blockade resulted in inhibition of ERK1/2 phosphorylation and up-regulation of IL-12 p35 and p40 mRNA expression. Importantly, mice pretreated with XVA143 elicited higher IL-12p70 and IFN-
levels in response to P. gingivalis i.p. infection and displayed enhanced pathogen clearance, compared with similarly infected controls. The notion that CR3 is associated with reduced IL-12p70 induction and impaired P. gingivalis clearance was confirmed using i.p. infected wild-type and CR3-deficient mice. Moreover, XVA143 dramatically attenuated the persistence and virulence of P. gingivalis in experimental mouse periodontitis, as evidenced by reduced induction of periodontal bone loss. Therefore, CR3 blockade may represent a promising immunomodulatory approach for controlling human periodontitis and possibly associated systemic diseases.
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 This work was supported by U.S. Public Health Service Grants DE015254 and DE018292 (to G.H.) from the National Institutes of Health.
2 Address correspondence and reprint requests to Dr. George Hajishengallis, University of Louisville Health Sciences Center, 501 South Preston Street, Room 206, Louisville, KY 40292. E-mail address: g0haji01{at}louisville.edu
3 Abbreviations used in this paper: CR3, complement receptor 3; ABC, alveolar bone crest; CEJ, cementoenamel junction; CHO, Chinese hamster ovary; PRR, pattern-recognition receptor.
This article has been cited by other articles:
|
|
 |
|
  C. R. Carter, J. P. Whitcomb, J. A. Campbell, R. M. Mukbel, and M. A. McDowell Complement Receptor 3 Deficiency Influences Lesion Progression during Leishmania major Infection in BALB/c Mice Infect. Immun., December 1, 2009; 77(12): 5668 - 5675. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. C. Monteiro, A. Scovino, S. Raposo, V. M. Gaze, C. Cruz, E. Svensjo, M. S. Narciso, A. P. Colombo, J. B. Pesquero, E. Feres-Filho, et al. Kinin Danger Signals Proteolytically Released by Gingipain Induce Fimbriae-Specific IFN-{gamma}- and IL-17-Producing T Cells in Mice Infected Intramucosally with Porphyromonas gingivalis J. Immunol., September 15, 2009; 183(6): 3700 - 3711. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Hajishengallis, M. Wang, and S. Liang Induction of Distinct TLR2-Mediated Proinflammatory and Proadhesive Signaling Pathways in Response to Porphyromonas gingivalis Fimbriae J. Immunol., June 1, 2009; 182(11): 6690 - 6696. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Hajishengallis, M. Wang, G. J. Bagby, and S. Nelson Importance of TLR2 in Early Innate Immune Response to Acute Pulmonary Infection with Porphyromonas gingivalis in Mice J. Immunol., September 15, 2008; 181(6): 4141 - 4149. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.L. Gaffen and G. Hajishengallis A New Inflammatory Cytokine on the Block: Re-thinking Periodontal Disease and the Th1/Th2 Paradigm in the Context of Th17 Cells and IL-17 Journal of Dental Research, September 1, 2008; 87(9): 817 - 828. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Sasaki, N. Suzuki, R. Kent Jr., N. Kawashima, J. Takeda, and P. Stashenko T Cell Response Mediated by Myeloid Cell-Derived IL-12 Is Responsible for Porphyromonas gingivalis-Induced Periodontitis in IL-10-Deficient Mice J. Immunol., May 1, 2008; 180(9): 6193 - 6198. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
